Categories: Stock Market

Vanguard Health Care (VHT) Shares Cross Above 200 DMA

In trading on Monday, shares of the Vanguard Health Care ETF (Symbol: VHT) crossed above their 200 day moving average of $240.03, changing hands as high as $240.65 per share. Vanguard Health Care shares are currently trading up about 0.9% on the day. The chart below shows the one year performance of VHT shares, versus its 200 day moving average:


Looking at the chart above, VHT’s low point in its 52 week range is $217.12 per share, with $265.79 as the 52 week high point — that compares with a last trade of $240.84.

Click here to find out which 9 other ETFs recently crossed above their 200 day moving average »

Also see:

• SWX YTD Return
• Top Ten Hedge Funds Holding ITHX
• Top Ten Hedge Funds Holding COLX

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Source link

nasdaqpicks.com

Share
Published by
nasdaqpicks.com

Recent Posts

AI-driven study abroad platform Vidysea raises $1M in seed funding

Vidysea Education Private Limited, a Noida-based AI-powered study abroad guidance platform, has secured $1 million…

48 seconds ago

Stock Market Strategy: Should investors buy the dip or turn to gold amid market correction?

The Indian stock market has been witnessing a sharp correction, with benchmark indices Sensex and…

1 minute ago

Why UK avoids picking a side in multipolar world

This article is an on-site version of our Inside Politics newsletter. Subscribers can sign up…

3 minutes ago

Airtel Payments Bank Q3 net up 70% at ₹18.5 crore

Airtel Payments Bank (APB) has reported a 70 percent increase in net profit for the…

8 minutes ago

Stocks to buy or sell for short-term: Jay Thakkar of ICICI Sec suggests these three shares in F&O segment

Stock Market News: The Indian stock market benchmark Sensex extended its losing streak to six…

12 minutes ago

Lupin to transfer OTC consumer healthcare business to wholly owned subsidiary for ₹550-650 crore

Drugmaker Lupin is transferring its over the counter (OTC) consumer healthcare business to a wholly…

15 minutes ago